日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fecal metabolic signals are associated with changes in microbiota and systemic metabolic pathways in Crohn's disease

粪便代谢信号与克罗恩病患者的肠道菌群和全身代谢途径的变化相关。

Levhar, Nina; Hadar, Rotem; Braun, Tzipi; Shacham, Hila; Algavi, Yadid; Naamneh, Raneen; Efroni, Gilat; Agranovich, Bella; Abramovich, Ifat; Talan Asher, Adi; Picard, Orit; Yavzori, Miri; Lahat, Adi; Yablecovitch, Doron; Kopylov, Uri; Denson, Lee; Borenstein, Elhanan; Eliakim, Rami; Ben-Horin, Shomron; Amir, Amnon; Haberman, Yael

Fecal and Serum Metabolome in Crohn's Disease is Linked With Future Flare

克罗恩病患者的粪便和血清代谢组与未来病情复发相关

Levhar, Nina; Hadar, Rotem; Braun, Tzipi; Naamneh, Raneen; Efroni, Gilat; Agranovich, Bella; Abramovich, Ifat; Asher, Adi Talan; Picard, Orit; Lahat, Adi; Yablecovitch, Doron; Kopylov, Uri; Eliakim, Rami; Ben-Horin, Shomron; Amir, Amnon; Haberman, Yael

Distal Fecal Wash Host Transcriptomics Identifies Inflammation Throughout the Colon and Terminal Ileum

远端粪便冲洗液宿主转录组学分析揭示结肠和末端回肠的炎症

Dan, Stav; Ungar, Bella; Ben-Moshe, Shani; Bahar Halpern, Keren; Yavzori, Miri; Fudim, Ella; Picard, Orit; Abitbol, Chaya Mushka; Harnik, Sivan; Barshack, Iris; Kopylov, Uri; Ben-Horin, Shomron; Itzkovitz, Shalev

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

维多珠单抗谷浓度能否预测炎症性肠病后续治疗的效果?

Levartovsky, Asaf; Cohen, Ido; Abitbol, Chaya Mushka; Yavzori, Miri; Fudim, Ella; Picard, Orit; Kopylov, Uri; Ben-Horin, Shomron; Ungar, Bella

Baseline Peripheral Blood Mononuclear Cell Transcriptomics Before Ustekinumab Treatment Is Linked With Crohn's Disease Clinical Response at 1 Year

乌司奴单抗治疗前外周血单核细胞转录组学与克罗恩病1年后的临床反应相关

Granot, Maya; Braun, Tzipi; Efroni, Gilat; Picard, Orit; Fudim, Ella; Yavzori, Miri; Haj, Ola; Weiss, Batia; Ben-Horin, Shomron; Kopylov, Uri; Haberman, Yael

Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening

延迟3天以上输注英夫利昔单抗会导致谷浓度显著降低,但不会导致临床症状恶化。

Ben-Shatach, Zohar; Ziv-Baran, Tomer; Fudim, Ella; Yavzori, Miri; Picard, Orit; Levartovsky, Asaf; Selinger, Limor; Weiss, Batia; Kopylov, Uri; Eliakim, Rami; Ungar, Bella

Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018

从以色列2017年和2018年加强对甲型肝炎病毒的监测中汲取的经验教训

Gozlan, Yael; Bar-Or, Itay; Volnowitz, Hadar; Asulin, Efrat; Rich, Rivka; Anis, Emilia; Shemer, Yonat; Szwarcwort Cohen, Moran; Dahary, Etti Levy; Schreiber, Licita; Goldiner, Ilana; Rozenberg, Orit; Picard, Orit; Savion, Michal; Fuchs, Inbal; Mendelson, Ella; Mor, Orna

SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses

犹太教堂社区的SARS-CoV-2疫情:抗SARS-CoV-2 IgG反应的持久性和强度

Gozlan, Yael; Reingold, Stephen; Koren, Ravit; Halpern, Osnat; Regev-Yochay, Gili; Cohen, Carmit; Biber, Asaf; Picard, Orit; Mendelson, Ella; Lustig, Yaniv; Mor, Orna

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.

血清 MMP-9:一种预测静止期克罗恩病患者临床复发的新型生物标志物——事后分析

Yablecovitch Doron, Kopylov Uri, Lahat Adi, Amitai Michal M, Klang Eyal, Ben-Ami Shor Dana, Neuman Sandra, Levhar Nina, Fudim Ella, Avidan Benjamin, Laish Ido, Selinger Limor, Zingboim-Orbach Noam, Picard Orit, Yavzori Miri, Eliakim Rami, Ben-Horin Shomron

Characterization of hepatitis B and delta coinfection in Israel

以色列乙型肝炎和丁型肝炎合并感染的特征

Shirazi, Rachel; Ram, Daniela; Rakovsky, Aviya; Bucris, Efrat; Gozlan, Yael; Lustig, Yaniv; Shaked-Mishan, Pninit; Picard, Orit; Shemer-Avni, Yonat; Ben-Zvi, Haim; Halutz, Ora; Lurie, Yoav; Veizman, Ella; Carlebach, Matthias; Braun, Marius; Naftaly, Michal Cohen-; Shlomai, Amir; Safadi, Rifaat; Mendelson, Ella; Sklan, Ella H; Ben-Ari, Ziv; Mor, Orna